MCL-1 degradation mediated by JNK activation via MEKK1/TAK1-MKK4 contributes to anticancer activity of new tubulin inhibitor MT189. (Q39009587)
Jump to navigation
Jump to search
scientific article published on 31 March 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MCL-1 degradation mediated by JNK activation via MEKK1/TAK1-MKK4 contributes to anticancer activity of new tubulin inhibitor MT189. |
scientific article published on 31 March 2014 |
Statements
1 reference
MCL-1 degradation mediated by JNK activation via MEKK1/TAK1-MKK4 contributes to anticancer activity of new tubulin inhibitor MT189. (English)
1 reference
Wei Wang
1 reference
Ying-Qing Wang
1 reference
Tao Meng
1 reference
Jun-Mei Yi
1 reference
Xia-Juan Huan
1 reference
Lan-Ping Ma
1 reference
Lin-Jiang Tong
1 reference
Yi Chen
1 reference
Jian Ding
1 reference
Jing-Kang Shen
1 reference
Ze-Hong Miao
1 reference
31 March 2014
1 reference
1 reference
13
1 reference
6
1 reference
1480-1491
1 reference
Identifiers
1 reference
1 reference